- AKRX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $73.7 million.
- AKRX is down 2.1% today from today's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in AKRX with the Ticky from Trade-Ideas. See the FREE profile for AKRX NOW at Trade-Ideas More details on AKRX: Akorn, Inc. manufactures and markets diagnostic and therapeutic ophthalmic pharmaceuticals, niche hospital drugs, and injectable pharmaceuticals in the United States and internationally. AKRX has a PE ratio of 108.7. Currently there are 6 analysts that rate Akorn a buy, no analysts rate it a sell, and 2 rate it a hold. The average volume for Akorn has been 1.3 million shares per day over the past 30 days. Akorn has a market cap of $4.6 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.48 and a short float of 15.9% with 6.46 days to cover. Shares are up 78% year-to-date as of the close of trading on Monday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.